Convatec GroupLSE:CTEC +0.56%77 PEG Ratio is 2.41 as of Jul. 01, 2026, which is 74% below its 10-year median of 9.27. GuruFocus rates LSE:CTEC with a GF Score™ of 77/100 and a GF Value™ of £2.57 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 207 Medical Devices & Instruments companies, Convatec Group ranks worse than 60.39% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Convatec Group's PEG Ratio or its related term are showing as below:
LSE:CTEC'
s PEG Ratio Range Over the Past 10 Years
Min: 1.8 Med: 9.27 Max: 33.27
Current: 2.41
During the past 13 years, Convatec Group's highest PEG Ratio was 33.27. The lowest was 1.80. And the median was 9.27.
LSE:CTEC's PEG Ratio is ranked worse than 60.39% of 207
companies
in the Medical Devices & Instruments industry
Industry Median: 2.03
vs LSE:CTEC: 2.41
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Convatec Group (LSE:CTEC) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Convatec Group PEG Ratio Related Terms
Convatec Group PEG Ratio Historical Data
* Premium members only.
The historical data trend for Convatec Group's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Convatec Group's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Convatec Group PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Convatec Group's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Convatec Group's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Convatec Group (LSE:CTEC) has a PEG Ratio of 2.41 as of Jul. 01, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Convatec Group and its competitors. This is 74% below median its historical median of 9.27. Over the past decade, Convatec Group's PEG Ratio has ranged from 1.80 to 33.27. According to the industry distribution chart, Convatec Group ranks #125 out of 207 companies in the Medical Devices & Instruments industry, placing it in the top 60.4%.
Is Convatec Group's PEG Ratio too high?
Convatec Group's current PEG Ratio of 2.41 is 74% below median its 10-year median of 9.27. Over the past 10 years, this metric has ranged from a low of 1.80 to a high of 33.27. The Medical Devices & Instruments industry median PEG Ratio is 2.03. Convatec Group's value of 2.41 is 18.7% above this industry median. Based on the distribution chart, Convatec Group ranks #125 out of 207 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Convatec Group has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Convatec Group's PEG Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Convatec Group ranks #125 out of 207 companies for PEG Ratio. This places Convatec Group in the lower half of its industry. The industry median PEG Ratio is 2.03. Convatec Group's value of 2.41 is 18.7% above this benchmark. Historically, Convatec Group's own PEG Ratio has ranged from 1.80 to 33.27 over the past decade. While the company's 10-year median is 9.27 vs. the industry median of 2.03, Convatec Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 2.03, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Convatec Group's current PEG Ratio of 2.41 is 18.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Convatec Group and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Convatec Group's current PEG Ratio is 2.41, which is 74% below median its own 10-year median of 9.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Convatec Group stock overvalued right now?
Based on GuruFocus' analysis, Convatec Group (LSE:CTEC) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.57, compared to a current price of £2.15 — trading 16.3% below its estimated fair value. The current PEG Ratio is 2.41, which is 74% below median its 10-year median of 9.27 and 18.7% above the Medical Devices & Instruments industry median of 2.03. Convatec Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Convatec Group (LSE:CTEC), the current PEG Ratio is 2.41 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Convatec Group (LSE:CTEC) Overvalued in 2026?
Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued.
The current stock price of £2.15 is trading 16.3% below its estimated GF Value™ of £2.57.
GuruFocus considers Convatec Group to be Modestly Undervalued.
Key valuation signals for LSE:CTEC:
PEG Ratio: 2.41 (74% below median its 10-year median of 9.27)
GF Value™: £2.57 vs. price of £2.15 (16.3% below fair value)
Industry Position: 18.7% above the Medical Devices & Instruments median (#125 of 207)
No single metric tells the full story. See the LSE:CTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score
Get the complete analysis for LSE:CTEC
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:CTEC has been successfully added to your 
